CLARENCE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is focused on tobacco harm reduction and hemp research, announced today that the Company filed its 2017 Annual Report on Form 10-K with the U.S. Securities and Exchange … Read More
The post 22nd Century Group Files 2017 Annual Report and Announces Conference Call to Provide … appeared first on Dagga Magazine.